[Mucoepidermoid carcinoma of the parotid gland as a secondary malignancy developed ten years after chemotherapy for childhood acute lymphoblastic leukemia]

Rinsho Ketsueki. 2007 Jun;48(6):491-4.
[Article in Japanese]

Abstract

We report on a case of mucoepidermoid carcinoma of the parotid gland following treatment of acute lymphoblastic leukemia (ALL) in childhood. The female patient was diagnosed as having T-cell ALL at the age of 13 years. Treatment included multidrug chemotherapy and prophylactic 18 Gy cranial irradiation. She developed low-grade mucoepidermoid carcinoma of the right parotid gland at the age of 24 years, the most probable cause of the secondary malignancy being radiation. In a literature review of mucoepidermoid carcinoma following ALL, 11 out of 14 cases received radiation therapy for the initial treatment of ALL, but 3 cases had no radiation therapy. The parotid gland carcinoma as a secondary malignancy following ALL in childhood is rare, but it highlights the need for concern about the secondary malignancy in patients with painless parotid swelling after chemoradiotherapy.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Mucoepidermoid / diagnosis
  • Carcinoma, Mucoepidermoid / drug therapy
  • Carcinoma, Mucoepidermoid / etiology*
  • Carcinoma, Mucoepidermoid / radiotherapy
  • Combined Modality Therapy
  • Female
  • Humans
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / drug therapy
  • Neoplasms, Second Primary / etiology*
  • Neoplasms, Second Primary / radiotherapy
  • Parotid Neoplasms / diagnosis
  • Parotid Neoplasms / drug therapy
  • Parotid Neoplasms / etiology*
  • Parotid Neoplasms / radiotherapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy*
  • Radiotherapy / adverse effects
  • T-Lymphocytes
  • Time Factors
  • Treatment Outcome